Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
- PMID: 32477008
- PMCID: PMC7240997
- DOI: 10.1186/s12935-020-01267-y
Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
Abstract
Background: The purpose of this study is to perform bioinformatics analysis of autophagy-related genes in gastric cancer, and to construct a multi-gene joint signature for predicting the prognosis of gastric cancer.
Methods: GO and KEGG analysis were applied for differentially expressed autophagy-related genes in gastric cancer, and PPI network was constructed in Cytoscape software. In order to optimize the prognosis evaluation system of gastric cancer, we established a prognosis model integrating autophagy-related genes. We used single factor Cox proportional risk regression analysis to screen genes related to prognosis from 204 autophagy-related genes in The Atlas Cancer Genome (TCGA) gastric cancer cohort. Then, the generated genes were applied to the Least Absolute Shrinkage and Selection Operator (LASSO). Finally, the selected genes were further included in the multivariate Cox proportional hazard regression analysis to establish the prognosis model. According to the median risk score, patients were divided into high-risk group and low-risk group, and survival analysis was conducted to evaluate the prognostic value of risk score. Finally, by combining clinic-pathological features and prognostic gene signatures, a nomogram was established to predict individual survival probability.
Results: GO analysis showed that the 28 differently expressed autophagy-related genes was enriched in cell growth, neuron death, and regulation of cell growth. KEGG analysis showed that the 28 differently expressed autophagy-related genes were related to platinum drug resistance, apoptosis and p53 signaling pathway. The risk score was constructed based on 4 genes (GRID2, ATG4D,GABARAPL2, CXCR4), and gastric cancer patients were significantly divided into high-risk and low-risk groups according to overall survival. In multivariate Cox regression analysis, risk score was still an independent prognostic factor (HR = 1.922, 95% CI = 1.573-2.349, P < 0.001). Cumulative curve showed that the survival time of patients with low-risk score was significantly longer than that of patients with high-risk score (P < 0.001). The external data GSE62254 proved that nomograph had a great ability to evaluate the prognosis of individual gastric cancer patients.
Conclusions: This study provides a potential prognostic marker for predicting the prognosis of GC patients and the molecular biology of GC autophagy.
Keywords: Autophagy; Bioinformatics; Gastric cancer; Prognosis.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures






Similar articles
-
Construction and Validation of Prognostic Markers of Liver Cancer Based on Autophagy Genes.Anticancer Agents Med Chem. 2021;21(14):1921-1930. doi: 10.2174/1871520621666210329100052. Anticancer Agents Med Chem. 2021. PMID: 33781194
-
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].Zhongguo Fei Ai Za Zhi. 2021 Aug 20;24(8):557-566. doi: 10.3779/j.issn.1009-3419.2021.103.09. Epub 2021 Jul 14. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34256900 Free PMC article. Chinese.
-
Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.Int J Biol Sci. 2020 Feb 10;16(7):1153-1165. doi: 10.7150/ijbs.41587. eCollection 2020. Int J Biol Sci. 2020. PMID: 32174791 Free PMC article.
-
Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.Front Oncol. 2020 May 5;10:707. doi: 10.3389/fonc.2020.00707. eCollection 2020. Front Oncol. 2020. PMID: 32432045 Free PMC article.
-
Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.Front Oncol. 2020 Oct 16;10:558596. doi: 10.3389/fonc.2020.558596. eCollection 2020. Front Oncol. 2020. PMID: 33178587 Free PMC article.
Cited by
-
Role of autophagy in gastric carcinogenesis.World J Gastrointest Oncol. 2021 Oct 15;13(10):1244-1262. doi: 10.4251/wjgo.v13.i10.1244. World J Gastrointest Oncol. 2021. PMID: 34721765 Free PMC article. Review.
-
A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer.Pharmaceuticals (Basel). 2022 Nov 14;15(11):1401. doi: 10.3390/ph15111401. Pharmaceuticals (Basel). 2022. PMID: 36422531 Free PMC article.
-
A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.Int J Gen Med. 2021 Oct 19;14:6935-6950. doi: 10.2147/IJGM.S331959. eCollection 2021. Int J Gen Med. 2021. PMID: 34703297 Free PMC article.
-
LC3B, mTOR, AMPK Are Molecular Targets for Neoadjuvant Chemotherapy in Gastric Cancers.Curr Issues Mol Biol. 2022 Jun 26;44(7):2772-2782. doi: 10.3390/cimb44070190. Curr Issues Mol Biol. 2022. PMID: 35877414 Free PMC article.
-
Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer.Cancer Cell Int. 2021 Jul 8;21(1):362. doi: 10.1186/s12935-021-02073-w. Cancer Cell Int. 2021. PMID: 34238288 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous